JPWO2020176757A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020176757A5
JPWO2020176757A5 JP2021549973A JP2021549973A JPWO2020176757A5 JP WO2020176757 A5 JPWO2020176757 A5 JP WO2020176757A5 JP 2021549973 A JP2021549973 A JP 2021549973A JP 2021549973 A JP2021549973 A JP 2021549973A JP WO2020176757 A5 JPWO2020176757 A5 JP WO2020176757A5
Authority
JP
Japan
Prior art keywords
cycloalkyl
alkyl
alkenyl
alkynyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021549973A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022522694A5 (https=
JP7704680B2 (ja
JP2022522694A (ja
Publication date
Priority claimed from US16/287,805 external-priority patent/US11098040B2/en
Application filed filed Critical
Priority claimed from PCT/US2020/020150 external-priority patent/WO2020176757A1/en
Publication of JP2022522694A publication Critical patent/JP2022522694A/ja
Publication of JP2022522694A5 publication Critical patent/JP2022522694A5/ja
Publication of JPWO2020176757A5 publication Critical patent/JPWO2020176757A5/ja
Application granted granted Critical
Publication of JP7704680B2 publication Critical patent/JP7704680B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021549973A 2019-02-27 2020-02-27 フェロトーシス誘導活性を有する化合物およびそれらの使用方法 Active JP7704680B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
USPCT/US2019/019854 2019-02-27
US16/287,805 US11098040B2 (en) 2018-02-28 2019-02-27 Compounds and methods of use
PCT/US2019/019854 WO2019168999A1 (en) 2018-02-28 2019-02-27 Compounds with ferroptosis inducing activity and methods of their use
US16/287,805 2019-02-27
US201962893092P 2019-08-28 2019-08-28
US62/893,092 2019-08-28
PCT/US2020/020150 WO2020176757A1 (en) 2019-02-27 2020-02-27 Compounds with ferroptosis inducing activity and methods of their use

Publications (4)

Publication Number Publication Date
JP2022522694A JP2022522694A (ja) 2022-04-20
JP2022522694A5 JP2022522694A5 (https=) 2023-03-03
JPWO2020176757A5 true JPWO2020176757A5 (https=) 2023-03-03
JP7704680B2 JP7704680B2 (ja) 2025-07-08

Family

ID=72238937

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021549973A Active JP7704680B2 (ja) 2019-02-27 2020-02-27 フェロトーシス誘導活性を有する化合物およびそれらの使用方法

Country Status (14)

Country Link
EP (1) EP3931183B1 (https=)
JP (1) JP7704680B2 (https=)
KR (1) KR20220012221A (https=)
CN (1) CN114008024A (https=)
AU (1) AU2020228056A1 (https=)
BR (1) BR112021016833A2 (https=)
CA (1) CA3131385A1 (https=)
EA (1) EA202192122A1 (https=)
ES (1) ES3013815T3 (https=)
IL (1) IL285730A (https=)
MX (1) MX2021010173A (https=)
SG (1) SG11202109035QA (https=)
TW (1) TW202045480A (https=)
WO (1) WO2020176757A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
TW202000663A (zh) 2018-02-28 2020-01-01 美商費洛醫療公司 化合物及使用方法
US11040964B2 (en) 2019-02-27 2021-06-22 Ferro Therapeutics, Inc. Compounds and methods of use
TW202227399A (zh) * 2020-08-26 2022-07-16 美商費洛醫療公司 化合物及使用方法
KR102759930B1 (ko) * 2022-01-17 2025-01-23 포항공과대학교 산학협력단 Marh6(marchf6) 조절제를 포함하는, 페로토시스 조절용 조성물 및 방법
WO2024015637A1 (en) * 2022-07-15 2024-01-18 Ferro Therapeutics, Inc. Glutathione peroxidase 4 (gpx4) inhibitors for the treatment of cancer
CN114984019B (zh) * 2022-07-15 2023-08-22 山东中医药大学 一种铁死亡抑制剂化合物及在肝损伤修复领域的应用
CN117209521A (zh) * 2022-11-04 2023-12-12 台州道致科技股份有限公司 丙炔酰氯制备方法
CN116983310B (zh) * 2023-08-29 2024-04-30 南方医科大学南方医院 一种治疗肝癌的药物组合物及其应用
CN118047698A (zh) * 2024-01-30 2024-05-17 山东科巢生物制药有限公司 一种n-[(1r)-2-[1,1'-联苯]-4-基-1-(羟基甲基)乙基]氨基甲酸叔丁酯的制备方法
CN118994147B (zh) * 2024-07-18 2026-01-02 中国海洋大学 一种基于疏水标签的gpx4蛋白降解剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03004023A (es) * 2000-11-08 2004-02-12 Lilly Icos Llc Compuestos quimicos.
EP3791870A1 (en) * 2013-12-02 2021-03-17 The Trustees of Columbia University in the City of New York Modulating ferroptosis and treating excitotoxic disorders
AU2016311426B2 (en) * 2015-08-26 2021-05-20 Blueprint Medicines Corporation Compounds and compositions useful for treating disorders related to NTRK
US20190008961A1 (en) * 2016-01-07 2019-01-10 The Broad Institute, Inc. Compounds and methods for increasing tumor infiltration by immune cells
WO2018118711A1 (en) * 2016-12-19 2018-06-28 The Trustees Of Columbia University In The City Of New York Small molecule ferroptosis inducers
TW202000663A (zh) * 2018-02-28 2020-01-01 美商費洛醫療公司 化合物及使用方法
JP2023509359A (ja) * 2019-12-17 2023-03-08 フラグシップ パイオニアリング イノベーションズ ブイ,インコーポレーテッド 鉄依存性細胞分解の誘導物質との併用抗癌療法
CN113336748B (zh) * 2021-04-12 2022-03-25 北京大学 一种gpx4蛋白降解剂及其制备方法和应用、一种抗肿瘤细胞药物

Similar Documents

Publication Publication Date Title
JP2021515010A5 (https=)
JPWO2020176757A5 (https=)
JPWO2019168999A5 (https=)
JP2005519083A5 (https=)
RU2012117829A (ru) Фосфорамидатные производные нуклеозидов
JP2008526999A5 (https=)
RU2004106555A (ru) Производные фенэтаноламина для лечения респираторных заболеваний
JP2011529918A5 (https=)
JP2011529069A5 (https=)
JP2020507589A5 (https=)
WO2010042684A4 (en) Pyrrolotriazine kinase inhibitors
JP2017519754A5 (https=)
JP2018109017A5 (https=)
JP2022137237A5 (https=)
JPWO2022251502A5 (https=)
JP2010505865A5 (https=)
CN105452259A (zh) 三环苯并氧杂硼化合物、其制备方法与应用
PL118755B1 (en) Process for preparing novel derivatives of phenethanolamine
JPWO2023088233A5 (https=)
JP2017535566A5 (https=)
JP2025513454A5 (https=)
CN110612286A (zh) 氰基取代的稠合双环衍生物及其制备方法和用途
JP2005531563A5 (https=)
CA2511242A1 (en) Inhibitors of human tumor-expressed ccxckr2
HU211304A9 (en) Novel morpholinol compounds, their preparation and use